Orthogonality

Orthogonal Global Group Announces the Appointment of Mona Coyle to the Board of Directors

Retrieved on: 
Thursday, March 7, 2024
Blockchain, Regenerative medicine, ICU, AI, Orthogonality, KZ2, Health, OTC Markets Group, Entrepreneurship, Longevity, Medicine

Mrs. Coyle is a Registered Nurse with over a decade of ICU and clinical operations experience.

Key Points: 
  • Mrs. Coyle is a Registered Nurse with over a decade of ICU and clinical operations experience.
  • She has more than 20 years in management and business development, including extensive experience in influencing strategic directions in healthcare.
  • “We are excited to have Mrs. Coyle as the new independent director on the Company’s board of directors.
  • The appointment of Mrs. Coyle follows the resignation of Mr. Mike Grantis from the Board, effective immediately.

Web3 Ventures Expands Portfolio With Acquisition of Unstoppable Domains Shares From Pluto 11.11, Announces Changes to Board of Directors, Announces Amendment of Its Existing Equity Incentive Plan, and Issues Options and Restricted Share Units to Eligible

Retrieved on: 
Wednesday, September 6, 2023
NFT, FOR, Internet, University, Acquisition, Transaction, Toronto Stock Exchange, Health, Lion Air Group, London Stock Exchange, MVS, Alternative Investment Market, USD, NYSE American, Orthogonality, Option, Knowledge, Multilateral, Anesthesiology, PLUS Markets Group, SVS, NOT, CAD, Medicine, Domain, Medical school, RSU, MI, ROFR, Person, Texas Tech University, American Stock Exchange Building, London, PLUS, Cryptocurrency, Security (finance), Pluto

TORONTO, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Web3 Ventures (the “Company”) is excited to announce its recent acquisition of 24,084 Series A-1 Preferred Stock of Unstoppable Domains Inc. (“Unstoppable Domains”) from Pluto 11.11 Inc. (“Pluto”) value of USD $1,110,978.07 in exchange for 302,186 multiple voting shares (“MVS Shares”) in the capital of the Company valued at CAD$5.00 each (the “Transaction”).

Key Points: 
  • Unstoppable Domains is at the forefront of revolutionizing digital identity and web presence by launching domains secured by blockchains and creating un-censorable websites.
  • "We are thrilled to welcome Unstoppable Domains to our portfolio,” said David Nikzad, CEO and Founder of the Company.
  • “This acquisition aligns perfectly with our vision of enabling a more decentralized and secure internet.
  • The Company is pleased to announce that it has approved the issuance of 10,550,000 options and 1,000,00 RSUs to eligible persons under the 2023 Equity Incentive Plan.

Orthogonal Thinker Inc. and Pluto 11.11 Inc. Provide Early Warning Disclosure for Investment in Web3 Ventures Inc.

Retrieved on: 
Thursday, March 23, 2023
OT, Exercise, Purchasing, SVS, NOT, FOR, Funding, Procurement, MVS, Sellers, Related, Person, Suite, Orthogonality, Option, National instrument, NI, News, Security (finance), Unit, Pluto

TORONTO, March 22, 2023 (GLOBE NEWSWIRE) -- Orthogonal Thinker Inc. (“OT”) and Pluto 11.11 Inc. (“Pluto”), announce today that they have acquired ownership of and control over securities of Web3 Ventures Inc. (the “Company” or “W3V”) pursuant to the previously announced non-brokered private placement of W3V (the “Financing”) and the previously announced securities purchase transaction described in the Company’s news release of March 21, 2023 (the “Purchase Transaction”) both of which have now closed.

Key Points: 
  • Each SVS Warrant is exercisable for a period of two years following the date of issue, at an exercise price of C$0.15 per SVS.
  • Each MVS Warrant is exercisable for a period of two years following the date of issue, at an exercise price of C$15.00 per MVS.
  • The early warning reports to be filed by Pluto and Orthogonal will be filed jointly in reliance upon Section 3.2 of National Instrument 62-103 - The Early Warning System and Related Take-Over Bid and Insider Reporting Issues.
  • A copy of the early warning reports filed by OT and Pluto will be available under the Company’s SEDAR profile, or by contacting David Nikzad, Chief Executive Officer of OT and Pluto at 808-213-8191.

Orthogonal Thinker Launches $10M USD Fundraising Round to Expand Holdings and Accelerate its Liquidity Pathway

Retrieved on: 
Tuesday, January 31, 2023
Growth, SAFE, Orthogonality, Family, Fintech, Investment, LOS, Security (finance), Space

Orthogonal plans to use the funds to continue to scale its operations and strategic partnerships into its main verticals: Wellness, Web 3.0, FinTech, and Space.

Key Points: 
  • Orthogonal plans to use the funds to continue to scale its operations and strategic partnerships into its main verticals: Wellness, Web 3.0, FinTech, and Space.
  • Orthogonal Thinker was founded on the shores of Hawaii and has since expanded into the U.S. mainland and abroad.
  • For investors in previous financing rounds, those investments have been converted into shares of Orthogonal Thinker at a share price of $23.27.
  • Powered by the industry leading funding platform, KoreConX, this Regulation D financing round is only open to accredited U.S. investors.

Exhibition Place Debuts Wi-Fi 6 at Beanfield Centre, Enhancing Its Premier Offerings with Cutting Edge Technology

Retrieved on: 
Thursday, June 16, 2022
Zero, Carbon, Langkawi Sky Bridge, Climate change, Silver, Industry, Hotel X Toronto, Culture, Exhibition, Automotive Building, Technology, Internet, LEED, Enercare Centre, Orthogonality, Exhibition Place, Paris, Recreation, Tourism, General manager, Wi-Fi, Skyway, Twitter, Leadership in Energy and Environmental Design, Instagram, Singing, Orthogonal frequency-division multiple access, Internet service provider, Consumer electronics, Interior design, Renewable energy, IEEE 802.11ax-2021, Facebook

TORONTO, June 16, 2022 /CNW/ - Building on a tradition of innovation in the Canadian convention and exhibition industry, Exhibition Place debuted Wi-Fi 6 at Beanfield Centre today.

Key Points: 
  • TORONTO, June 16, 2022 /CNW/ - Building on a tradition of innovation in the Canadian convention and exhibition industry, Exhibition Place debuted Wi-Fi 6 at Beanfield Centre today.
  • We are meeting and exceeding these demands by offering complimentary WiFi to all convention and exhibition clients, exhibitors and attendees at Enercare Centre and Beanfield Centre.
  • Exhibition Place is Canada's largest entertainment and convention site, attracting over 5.5 million visitors a year.
  • Exhibition Place boasts the award-winning, LEED Platinum Enercare Centre; Canada's largest exhibition and convention centre, and the Beanfield Centre LEED Silver conference venue.

MD&M West Reveals 2022 Educational MedTech Conference Content: 3D Printing and Biomaterials to Robotics and Digital Health

Retrieved on: 
Monday, February 28, 2022
Technology, Medical Devices, Packaging, Engineering, Chemicals, Plastics, Other Technology, Manufacturing, Biotechnology, General Health, Health, Cloud computing, COVID-19, Stroke, Plastic, Anaheim Convention Center, Neoplasm, Device file, TAVR, Solution, Engineer, Health, Role, Growth, ATX, Diet, Orthogonality, Arrhythmia, Safety, Disease, Adoption, Exercise, Engineering, Design manufacture service, IVD, CEO, Argentine Society of Plastic, Reconstructive and Aesthetic Surgery, D, CLS, Element, Medtech, Arm, BNP, Patient, UCLA, AAMI, Science, Medtronic, CRISPR, Ethicon Inc., Anatomy, Stryker, Data science, Industry, Medicine, Heart, Pathology, Single-frequency network, Tech Coast Angels, Cancer, Conference, Technology, Association, Standard of care, MD, Video game, Medical device, Pharmaceutical industry, Informa Markets – Engineering, Informa Markets, INFORMA MARKETS – ENGINEERING, INFORMA MARKETS

Were proud to partner with MD&M West and look forward to supporting the upcoming event that will help drive the life sciences industry forward.

Key Points: 
  • Were proud to partner with MD&M West and look forward to supporting the upcoming event that will help drive the life sciences industry forward.
  • "Even amid unprecedented challenges, we're continuing to see new life-saving innovations and exciting partnerships arise that are fueling the multi-hundred-billion-dollar industry," said Adrienne Zepeda, Group Event Director, MD&M West.
  • At-home diagnostics is here to stay, but getting an IVD product from concept development to market is filled with many questions and challenges.
  • Join industry expert Dr. Lishan Aklog as he shares both trials and success stories and leaves you with insights into how to avoid problem areas.

SILEX TECHNOLOGY ANNOUNCES FIRST WI-FI 6E SOLUTION FOR EMBEDDED MEDICAL AND INDUSTRIAL IOT DEVICES

Retrieved on: 
Thursday, January 6, 2022
NVIDIA, Linux, Communication, IEEE 802.11ax-2021, Orthogonal frequency-division multiplexing, Orthogonality, OFDMA, Life, NXP, Qualcomm, TWT, Wireless, Orthogonal frequency-division multiple access, Internet of things, Efficiency, Hertz, LAN, Certification, Phoenix Contact, IOT, Microsoft Windows, Internet service provider, Mobile phone, Communications satellite, Nvidia, Wi-Fi, Silex

The SX-PCEAX is a tri-band (2.4GHz / 5GHz / 6GHz) wireless LAN combo module that supports Wi-Fi 6E + Bluetooth v5.2, using Qualcomm QCA2066.

Key Points: 
  • The SX-PCEAX is a tri-band (2.4GHz / 5GHz / 6GHz) wireless LAN combo module that supports Wi-Fi 6E + Bluetooth v5.2, using Qualcomm QCA2066.
  • Customers designing medical and industrial devices can now jump to Wi-Fi 6E for better performance, less crowded networks, and a longer lifecycle for their designs.
  • Why Silex for Wi-Fi 6E:
    As one of the select few Qualcomm Design Centers globally, Silex provides leading wireless technology with design support worldwide.
  • Target Wake Time (TWT): Significantly improves battery life in Wi-Fi devices, such as Internet of Things (IoT) devices.

Mycotopia Therapies Announces Ei.Ventures Acquires 12x12 Estate in The Sandbox in Anticipation of PSLY.COM Launch Post-Merger with Mycotopia Therapies in Q1 2022

Retrieved on: 
Thursday, January 6, 2022
Ethereum, Health, Sand, Reg, Failure, Company, Research, Form, Forward-looking statement, MetaMask, Orthogonality, Risk, COVID, U.S. Securities and Exchange Commission, Cannabis, Alternative medicine, Psychotherapy, Security (finance), EI, CEO, SEC, Y Combinator, Blockchain, Cryptocurrency, TPIA, Sale, GLOBE, Wellness, Technology, Emotional Intelligence, OTC Markets Group, Forbes, Metaverse, Sandbox

The land will be called PSLY.COM, the name of the soon to be merged company of Ei.Ventures with Mycotopia Therapies.

Key Points: 
  • The land will be called PSLY.COM, the name of the soon to be merged company of Ei.Ventures with Mycotopia Therapies.
  • Herrington titled Startup Plans Psychedelic Trips In The Metaverse With Sandbox Virtual Land Deal .
  • We are very excited to invite all of our portfolio companies and investors to be part of something very special.
  • Ei.Ventures now owns 144 pieces of Sandbox land that make up this 12 x 12 estate.

Ei.Ventures and Orthogonal Thinker Acquire 12x12 Estate in The Sandbox in Anticipation of PSLY.COM Launch Post-Merger with Mycotopia Therapies in Q1 2022

Retrieved on: 
Thursday, January 6, 2022
Technology, General Health, Health, Other Technology, Ethereum, Time, Health, Acquisition, Company, Forward-looking statement, MetaMask, Orthogonality, Goal, COVID, Cannabis, Alternative medicine, EI, Y Combinator, Sale, Wellness, Multimedia, VR, Cryptocurrency, Metaverse

The land will be called PSLY.COM, the name of the soon-to-be merged company of Ei.Ventures with Mycotopia Therapies .

Key Points: 
  • The land will be called PSLY.COM, the name of the soon-to-be merged company of Ei.Ventures with Mycotopia Therapies .
  • View the full release here: https://www.businesswire.com/news/home/20220105005972/en/
    PSLY.COM's real estate on The Sandbox.
  • We are very excited to invite all of our portfolio companies and investors to be part of something extraordinary.
  • Ei.Ventures now owns 144 pieces of Sandbox land that make up this 12x12 estate.

Synthekine Announces Publication of Preclinical Data Demonstrating In Vivo Control of CD19 CAR-T Cells with its Orthogonal IL-2 System

Retrieved on: 
Thursday, December 23, 2021
Biotechnology, Pharmaceutical, Health, Oncology, ACT, CD19, Orthogonality, Science Translational Medicine, Cytokine, Patient, LinkedIn, Toxic shock syndrome, ACTS, IND, Inflammation, Therapy, Immune system, Cancer, Inc., Lymphoma, Twitter, FDA, Vaccine

Synthekine Inc., an engineered cytokine therapeutics company, today announced the publication of preclinical data for its lead cell therapy program using the orthogonal IL-2 receptor/ligand system in Science Translational Medicine.

Key Points: 
  • Synthekine Inc., an engineered cytokine therapeutics company, today announced the publication of preclinical data for its lead cell therapy program using the orthogonal IL-2 receptor/ligand system in Science Translational Medicine.
  • The published data shows STK-009, the orthogonal IL-2 ligand, enables the control of cell expansion and activation of a CD19 CAR-T cell therapy which expresses the orthogonal IL-2 receptor (SYNCAR-001) in preclinical models of human lymphoma.
  • The publication, titled An Orthogonal IL-2 and IL-2R System Drives Persistence and Activation of CAR-T Cells and Clearance of Bulky Lymphoma can be accessed here .
  • Synthekine designed its orthogonal IL-2 system to address these limitations of CD19 CAR-T cells and other adoptive cell therapies.